Crystalline tumor necrosis factor receptor 2 polypeptides

Details for Australian Patent Application No. 2004262014 (hide)

Owner Amgen Inc.

Inventors Bass, Randal B.; Clogston, Christi L.; Osslund, Timothy D.; Crampton, Shon Lee

Agent Freehills

Pub. Number AU-B-2004262014

PCT Pub. Number WO2005/012353

Priority 60/491,827 01.08.03 US

Filing date 29 July 2004

Wipo publication date 10 February 2005

Acceptance publication date 17 June 2010

International Classifications

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/012353 Priority application(s): WO2005/012353

17 June 2010 Application Accepted

  Published as AU-B-2004262014

14 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004262022-Accelerated vaccination

2004262007-Gelatin capsules